4.83
price down icon2.42%   -0.12
after-market 시간 외 거래: 5.45 0.62 +12.84%
loading

Pluri Inc 주식(PLUR)의 최신 뉴스

pulisher
Jun 13, 2025

Insiders Sold Pluri At US$5.87, Meanwhile Stock Sits Near US$4.30 - simplywall.st

Jun 13, 2025
pulisher
Jun 06, 2025

Plurilock Security (CVE:PLUR) Stock Price Up 7.8% – Here’s What Happened - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

Pluri (NASDAQ:PLUR) Now Covered by Alliance Global Partners - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Alliance Global Partners Initiates Coverage of Pluri (TASE:PLUR) with Buy Recommendation - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Alliance Global Partners Initiates Coverage of Pluri (PLUR) with Buy Recommendation - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Alliance Global Partners Initiates Coverage on Pluri (PLUR) with a "Buy" Rating | PLUR Stock News - GuruFocus

Jun 02, 2025
pulisher
May 28, 2025

BCLI: Receives Regulatory Clearance to Initiate Phase 3b ALS Trial… - MSN

May 28, 2025
pulisher
May 27, 2025

BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Pluri Inc. reschedules 2025 annual meeting By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Pluri Inc. reschedules 2025 annual meeting - Investing.com

May 27, 2025
pulisher
May 27, 2025

BrainStorm partners with Minaris for ALS therapy trial By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

BrainStorm partners with Minaris for ALS therapy trial - Investing.com

May 27, 2025
pulisher
May 27, 2025

BrainStorm Accelerates NurOwn ALS Treatment Development Through Major Manufacturing Deal with Minaris - Stock Titan

May 27, 2025
pulisher
May 24, 2025

Pluri (NASDAQ:PLUR) vs. CARGO Therapeutics (NASDAQ:CRGX) Head-To-Head Review - Defense World

May 24, 2025
pulisher
May 21, 2025

Cellular Therapeutics Market Poised for Explosive Growth, Driven by Innovative Companies - citybuzz -

May 21, 2025
pulisher
May 20, 2025

4 Stocks To Watch In The $47 Billion Cellular Therapeutics Market - FinancialContent

May 20, 2025
pulisher
May 15, 2025

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion - TradingView

May 15, 2025
pulisher
May 15, 2025

Pluri Achieves 400% Revenue Surge as Biotech Pioneer Enters $130B Cacao and Coffee Markets - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Pluri (NASDAQ:PLUR) & Qiagen (NYSE:QGEN) Head to Head Contrast - Defense World

May 14, 2025
pulisher
May 14, 2025

Pluri: Fiscal Q3 Earnings Snapshot - New Haven Register

May 14, 2025
pulisher
May 08, 2025

Pluri Regains Nasdaq Compliance Before Deadline - TipRanks

May 08, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Boosts Stock Position in Pluri Inc. (NASDAQ:PLUR) - Defense World

May 07, 2025
pulisher
May 06, 2025

Q&A with Alejandro Weinstein, Pluri Board of Directors - citybiz

May 06, 2025
pulisher
Apr 29, 2025

Pluri Inc. sets date for 2025 shareholder meeting By Investing.com - Investing.com Canada

Apr 29, 2025
pulisher
Apr 29, 2025

Pluri Inc. sets date for 2025 shareholder meeting - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Pluri acquires 71% stake in Kokomodo - Food Business News

Apr 29, 2025
pulisher
Apr 29, 2025

Pluri Inc. acquires majority stake in Kokomodo Ltd. By Investing.com - Investing.com Canada

Apr 29, 2025
pulisher
Apr 28, 2025

Pluri Acquires 71% Of Kokomodo To Advance Climate-Resilient Cultivated Cacao Production - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Pluri Inc. acquires majority stake in Kokomodo Ltd. - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

$13.5B Cacao Market Disruption: Pluri Acquires Cellular Agriculture Pioneer Kokomodo for Climate-Resilient Future - Stock Titan

Apr 28, 2025
pulisher
Apr 26, 2025

Pluri Inc. enters agreement, issues pre-funded warrants - Investing.com Australia

Apr 26, 2025
pulisher
Apr 26, 2025

Pluri Inc. enters agreement, issues pre-funded warrants By Investing.com - Investing.com Canada

Apr 26, 2025
pulisher
Apr 23, 2025

Pluristem stock soars to 52-week high, hits $6.63 By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Pluristem stock soars to 52-week high, hits $6.63 - Investing.com Australia

Apr 23, 2025
pulisher
Apr 21, 2025

DarioHealth Announces CFO Transition - The Malaysian Reserve

Apr 21, 2025
pulisher
Apr 21, 2025

DarioHealth Announces CFO Transition - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

DarioHealth Taps Israeli CFO Excellence Award Winner to Lead Next Growth Phase - Stock Titan

Apr 21, 2025
pulisher
Apr 18, 2025

Pluri Inc. subsidiary loses $4.2 million NIAID contract By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 17, 2025

Pluri Inc. subsidiary loses $4.2 million NIAID contract - Investing.com Australia

Apr 17, 2025
pulisher
Apr 17, 2025

Pluri IncPluri Biotech Receives Termination Notice From Niaid Of ContractSEC Filing - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Analyzing X4 Pharmaceuticals (NASDAQ:XFOR) & Pluri (NASDAQ:PLUR) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Pluri Inc. (NASDAQ:PLUR) Short Interest Update - Defense World

Apr 16, 2025
pulisher
Apr 11, 2025

Pluri’s immune cell expansion technologies gain patents - Yahoo Finance

Apr 11, 2025
pulisher
Apr 11, 2025

Pluri Announces Expansion of Intellectual Property Portfolio wit - GuruFocus

Apr 11, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):